Related Experiment Video
Updated: Jul 5, 2026
Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
Published on: December 5, 2025
Effect of Toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial
Lincoln S Smith1, Osamu Kajikawa, Greg Elson
1Division of Pediatric Critical Care, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
Abstract:
Mechanical ventilation (MV) and lipopolysaccharide (LPS) synergistically increase inflammation and lung injury. The goal of this study was to determine whether blockade of CD14 or Toll-like receptor 4 (TLR4) would reduce inflammation caused by LPS and MV. Rabbits were pretreated with anti-TLR4 or anti-CD14 monoclonal antibodies, followed by endobronchial LPS and MV. Blockade of TLR4 reduced the number of neutrophils and the amount of CXCL8 in bronchoalveolar lavage fluid. In contrast, blockade of CD14 did not significantly decrease the number of neutrophils or the amount of CXCL8. These data show that TLR4 blockade reduces pulmonary inflammation caused by the combination of LPS and Mechanical ventilation.
Insights
Blockading Toll-like receptor 4 (TLR4) significantly reduced lung inflammation and injury caused by mechanical ventilation (MV) and lipopolysaccharide (LPS). CD14 blockade showed no significant effect, indicating TLR4 is key in this inflammatory response.
Area of Science:
- Pulmonary Medicine
- Immunology
- Critical Care
Background:
- Mechanical ventilation (MV) and lipopolysaccharide (LPS) exposure synergistically exacerbate lung inflammation and injury.
- Toll-like receptor 4 (TLR4) and its co-receptor CD14 are critical mediators of inflammatory responses to LPS.
Purpose of the Study:
- To investigate the efficacy of blocking TLR4 or CD14 in mitigating lung inflammation induced by the combined challenge of LPS and MV.
Main Methods:
- Rabbits were pretreated with monoclonal antibodies targeting either TLR4 or CD14.
- Animals subsequently received endobronchial LPS followed by mechanical ventilation.
- Inflammatory markers, including neutrophil count and CXCL8 levels in bronchoalveolar lavage fluid, were assessed.
Main Results:
- TLR4 blockade significantly reduced neutrophil infiltration and CXCL8 levels in bronchoalveolar lavage fluid.
- CD14 blockade did not yield significant reductions in these inflammatory markers.
- These findings highlight a differential role for TLR4 and CD14 in this model.
Conclusions:
- TLR4 blockade is an effective strategy to reduce pulmonary inflammation resulting from the combined insult of LPS and mechanical ventilation.
- Targeting TLR4, rather than CD14, offers a promising therapeutic approach for ventilator-induced lung injury exacerbated by LPS.
